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License 4.0 (CC BY-NC).Mitochondrial protein-linked DNA breaks perturb
mitochondrial gene transcription and trigger free
radical–induced DNA damage
Shih-Chieh Chiang,1 Martin Meagher,2 Nick Kassouf,3 Majid Hafezparast,4
Peter J. McKinnon,5 Rachel Haywood,3 Sherif F. El-Khamisy1,6*Breakage of one strand of DNA is the most common form of DNA damage. Most damaged DNA termini require
end-processing in preparation for ligation. The importance of this step is highlighted by the association of de-
fects in the 3′-end processing enzyme tyrosyl DNA phosphodiesterase 1 (TDP1) and neurodegeneration and by
the cytotoxic induction of protein-linked DNA breaks (PDBs) and oxidized nucleic acid intermediates during
chemotherapy and radiotherapy. Although much is known about the repair of PDBs in the nucleus, little is
known about this process in the mitochondria. We reveal that TDP1 resolves mitochondrial PDBs (mtPDBs),
thereby promoting mitochondrial gene transcription. Overexpression of a toxic form of mitochondrial topo-
isomerase I (TOP1mt*), which generates excessive mtPDBs, results in a TDP1-dependent compensatory up-
regulation of mitochondrial gene transcription. In the absence of TDP1, the imbalance in transcription of
mitochondrial- and nuclear-encoded electron transport chain (ETC) subunits results in misassembly of ETC
complex III. Bioenergetics profiling further reveals that TDP1 promotes oxidative phosphorylation under both
basal and high energy demands. It is known that mitochondrial dysfunction results in free radical leakage and
nuclear DNA damage; however, the detection of intermediates of radical damage to DNA is yet to be shown.
Consequently, we report an increased accumulation of carbon-centered radicals in cells lacking TDP1, using
electron spin resonance spectroscopy. Overexpression of the antioxidant enzyme superoxide dismutase
1 (SOD1) reduces carbon-centered adducts and protects TDP1-deficient cells from oxidative stress. Conversely,
overexpression of the amyotrophic lateral sclerosis–associated mutant SOD1G93A leads to marked sensitivity.
Whereas Tdp1 knockout mice develop normally, overexpression of SOD1G93A suggests early embryonic lethal-
ity. Together, our data show that TDP1 resolves mtPDBs, thereby regulating mitochondrial gene transcription
and oxygen consumption by oxidative phosphorylation, thus conferring cellular protection against reactive
oxygen species–induced damage.INTRODUCTION
As aerobic organisms, our cells and geneticmaterials are under constant
exposure to toxic metabolites of respiration. The ability to detect and
repair free radical–induced damage is critical to maintaining the struc-
tural and functional integrity of cells. Failure in this response can result
in mutagenesis, inhibition of transcription, organelle dysfunction, and
cell death. Almost all DNA termini produced by endogenous or exog-
enous sources of DNA damage lack the conventional chemistries re-
quired for DNA ligation (3′-OH and 5′-PO4). Therefore, nature has
evolved a number of DNA end-processing enzymes to clean up damaged
DNA termini. Tyrosyl DNA phosphodiesterase 1 (TDP1) is a broad-
spectrum DNA end-processing enzyme that deals with a variety of
3′-damaged termini, including oxidized sugar/base fragments andTOP1
peptides (1–8). Progressive accumulation of unprocessed TDP1 sub-
strates causes neurodegeneration in humans, and their acute accumula-
tionhas beenused to improve anticancer and antiviral therapies (5, 9–17).
The neuroprotective role of TDP1 has been primarily attributed to
its nuclear DNA repair function, but its role in the mitochondria is lesswell understood. In cultured mammalian cells, TDP1 has been shown
to localize to the mitochondria, with putative roles in mitochondrial
DNA (mtDNA) replication following oxidative DNA damage (18–20).
The mitochondria play a pivotal role in the health of neuronal cells
by providing vital energy andmetabolizingmacromolecules throughout
the life span of cells. Reactive oxygen species (ROS) generated in the
mitochondria is an unavoidable by-product, which, if allowed to accu-
mulate, leads to a vicious cycle of mitochondrial dysfunction, leading to
more ROS production. Recent elegant studies have nicely shown the
importance of mitochondrial TOP1 (TOP1mt) in mitochondrial gene
transcription (21) and replication (22, 23) and in maintaining mito-
chondrial function (22–24). Similar to its nuclear counterpart,
TOP1mt removes negative and positive supercoils generated during
DNA transactions (25–27) and may potentially become trapped in
the vicinity ofmodifiedDNA bases (28–33). However, howmamma-
lian mitochondria resolve these lesions and their consequence onmito-
chondrial and cellular function remains to be tested (34). Here, we
report that TDP1 is able to resolve mitochondrial TOP1-linked DNA
breaks and functionally interacts with TOP1mt to regulate mitochon-
drial gene transcription, electron transport chain (ETC) complex III
assembly, and oxygen consumption, thereby conferring cellular pro-
tection against ROS-induced damage.RESULTS
To examine the putative role of TDP1 during mtDNA repair, we gen-
erated a doxycycline-inducible knockdown cell line and an isogenic1 of 15
SC I ENCE ADVANCES | R E S EARCH ART I C L Econtrol complemented with RNA interference (RNAi)–resistant
human TDP1 (hTDP1) (fig. S1A). We first confirmed efficient
TDP1 depletion using a biochemical activity assay with fluorophore-
labeled TDP1 substrates (fig. S1B), an alkaline comet assay measuring
the accumulation of camptothecin (CPT)–induced TOP1 breaks (fig.
S1C), and CPT survival assays (fig. S1D). We then engineered an
inducible system whereby depletion of TDP1 is simultaneously
achieved with the expression of either wild-type (WT) TOP1mt or a
version harboring the T554A/N558H mutation (TOP1mt*), which
specifically induces mitochondrial protein-linked DNA breaksChiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017(mtPDBs) by inhibiting the DNA religation activity of TOP1mt (Fig. 1A)
(33). Overexpression of TOP1mt* has advantages over topoisome-
rase poisons such as CPT, which also target the nuclear genome and
have limited mitochondrial permeability and activity due to the alka-
line nature of the mitochondrial matrix (25, 34–37).
To assess the extent of mtPDBs generated by overexpression of
TOP1mt and TOP1mt*, we purified TOP1mt DNA cleavage com-
plexes (TOP1mt-cc) frommitochondrial extracts using cesium chlo-
ride fractionation and antibodies against green fluorescent protein
(GFP) to detectTOP1mt-GFP– andTOP1mt*-GFP–linkedDNAbreaks.A
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Fig. 1. TDP1 promotes mitochondrial gene transcription in human cells. (A) Immunoblotting of Flp-In T-Rex 293 cell lines after doxycycline induction using anti-
bodies against TDP1, GFP, and b tubulin. TDP1 + miTDP1, TDP1-depleted cells overexpressing microRNA (miRNA)–resistant TDP1; miTDP1-4, TDP1-depleted cells (clone
4); TOP1mt + miScr, scrambled miRNA–transfected cells overexpressing TOP1mt-EmGFP; TOP1mt + miTDP1, miTDP1 cells overexpressing TOP1mt-EmGFP; TOP1mt* +
miScr, miScr cells overexpressing TOP1mtT554A,N558H-EmGFP; TOP1mt* + miTDP1, miTDP1 cells overexpressing TOP1mt554A,N558H-EmGFP. (B) Mitochondrial lysates from
doxycycline-induced cells were fractionated using CsCl gradient and immunoblotted using antibodies against GFP to detect TOP1mt- and TOP1mt*-linked DNA breaks.
Enhanced chemiluminescence intensity was quantified and expressed as fold increase relative to TOP1mt-expressing cells. (C) TOP1mt*-cc in doxycycline-induced cells
were immunoprecipitated using GFP-trap magnetic beads and the bound mtDNA at a putative TOP1mt*-binding site in the noncoding regulatory region quantified by
qPCR. The mtDNA copy numbers of each cell line were concomitantly measured using primers for the ND1 (mitochondrial) and B2M (nuclear) genes. Enrichment of
TOP1mt-bound chromatin is expressed as percent input, which is then normalized to the mitochondrial copy number of the cell line. (D to F and I) Total RNA from
doxycycline-induced cells from (A) was reverse-transcribed and analyzed by SYBR-Green–based qPCR using primers for mitochondrial-encoded genes. Mitochondrial
transcript levels were normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels and expressed as a fraction against the corresponding mito-
chondrial gene transcript in control scrambled miRNA–transfected (miScr) cells. Data are the means of three independent experiments, and error bars represent ±1 SEM.
(G) Mitochondrial lysates of doxycycline-induced cells were incubated with 5′-Cy5.5–labeled 18-mer substrate with a 3′-phosphotyrosine terminus (18-Y) that is pro-
cessed to 3′-phosphate (18-P) by TDP1. (H) Quantification of product conversion normalized to miScr cells from three independent experiments described in (G) using
LI-COR Image Studio Lite version 5.2. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.2 of 15
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TOP1mt-cc compared to control cells (fig. S2A), suggesting that human
cells have activities required to resolve TOP1mt-linked DNA breaks. Re-
peating the experiment inTDP1-depleted cells revealed an approximately
6.5-fold increase in TOP1mt-cc (Fig. 1B). Overexpression of TOP1mt*
induced ~6.5-fold more mtPDBs than WT TOP1mt, and TDP1 deple-
tion further increased this by another ~1.6-fold,which is ~10.7-fold above
TOP1mt overexpression alone (Fig. 1B). To confirm that the GFP signal
was specific toTOP1mt-GFP andTOP1mt*-GFP,wemade use of a new-
ly developed antibody against the TOP1-DNA covalent complex, which
detects the tertiary structure at the catalytic sites conserved between
TOP1 and TOP1mt (25, 38). Again, we observed more TOP1mt-cc in
TOP1mt*-overexpressing mitochondrial extracts than TOP1mt
extracts (fig. S2B). To further assess the role of TDP1 during mtPDB
repair, we compared TDP1-proficient andTDP1-deficient cells for levels
of TOP1mt*-boundmtDNA in the promoter-containing noncoding reg-
ulatory region, which is a known binding site for TOP1mt* (33). Deple-
tion of TDP1 led to an approximately fourfold increase in TOP1mt-cc,
as quantified by quantitative polymerase chain reaction (qPCR) (P <
0.05; Fig. 1C), which was not caused by a change in mtDNA template
abundance because mtDNA copy number was comparable across the
cell lines tested within each individual experiment (fig. S2C). Together,
we conclude that TDP1 is capable of resolving mitochondrial TOP1-
linked DNA breaks.
We then examined the role of TDP1 during mitochondrial gene
transcription. We analyzed multiple sites along the polycistronic
heavy-chain transcript, from the 5′-end RNR1 gene to the 3′-endCYTB
gene, to allow detection of primary transcripts of different lengths. In
agreement with published work (21), overexpression of TOP1mt led
to a marked reduction of the five mitochondrial mRNA transcripts
examined via quantitative reverse transcription PCR (qRT-PCR) (P <
0.001; Fig. 1D and fig. S2D). Consistent with a role of TDP1 during
mtPDB repair, depletion of TDP1 led to an approximately 50% reduc-
tion of all transcripts tested, which was partially rescued by
complementation with hTDP1 (P < 0.01; Fig. 1E). In striking contrast
to WT TOP1mt, overexpression of TOP1mt* led to an approximately
twofold increase inmitochondrial gene transcription (P < 0.05; Fig. 1F).
Given the observed role for TDP1 to process TOP1mt*-induced DNA
breaks (Fig. 1B), we reasoned that the increase in transcriptionmight be
due to a compensatory up-regulation of TDP1. This was indeed the
case, as shown by an approximately 25% increase in mitochondrial
TDP1 catalytic activity in cells overexpressing TOP1mt* (P < 0.05;
Fig. 1, G and H). Consistent with this, depletion of TDP1 was sufficient
to abrogate the TOP1mt*-induced transcription up-regulation (P <
0.05; Fig. 1I).
Because transcription ofmtDNA-encoded genes is essential for the
synthesis of major subunits of all the ETC complexes of the OXPHOS
system except complex II, we next assessed the assembly of these
complexes in purified mitochondria by probing for the subunits that
are particularly labile when the complexes are not correctly assembled
(Fig. 2A) (39). As expected, neither depletion of TDP1nor overexpres-
sion of TOP1mt* had a significant effect on the nuclear-encoded
complex II subunit SDHB at both the protein and mRNA levels
(Fig. 2, A andC, and fig. S3). Althoughwe did not observe a significant
reduction in the stability of complexes I, IV, andV (Fig. 2, B, E, and F),
the most noticeable difference was detected with complex III, which
was further confirmed by complex III–specific antibodies (Fig. 2A).
When normalized to the mitochondrial structural protein VDAC1
(porin), the level of UQCRC2 in complex III was reduced by ~40%Chiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017upon TDP1 depletion (P < 0.01; Fig. 2D). We conclude from these
experiments that TDP1 promotes the integrity of the ETC complex
III subunit.
Next, we examined whether the deregulation of complex III affects
the OXPHOS function of the ETC complexes by measuring cellular
oxygen consumption using the Seahorse Bioanalyzer. This technique
monitors real-time cellular oxygen consumption rate (OCR) under
basal conditions and following sequential challenges with the
adenosine 5′-triphosphate (ATP) synthase inhibitor oligomycin, the
mitochondrial membrane uncoupler FCCP, and the mitochondrial
complex I inhibitor rotenone. Suppression of all mitochondrial respira-
tion by rotenone and the complex III inhibitor antimycin-A allowed the
definition of the baseline levels of nonmitochondrialOCR (Fig. 3A).We
first examined the basal respiration of WT and TDP1-depleted cells.
Consistent with its role during mitochondrial gene transcription (Fig.
1E) and complex III assembly (Fig. 2D), TDP1 depletion resulted in
an approximately 25% reduction in OCR compared to WT cells (P <
0.01; Fig. 3B). Overexpression of TOP1mt* reduced basal respiration by
~30% (P < 0.05; Fig. 3C), and depletion of TDP1 in these cells had no
further detectable effect on basal respiration (Fig. 3D). The lower OCRs
were due to loss of ATP-coupled respiration (Fig. 3, E to G) because
inhibition of ATP-coupled respiration by oligomycin revealed no sig-
nificant changes in uncoupled respiration (proton leak) across the cell
lines (fig. S4). Upon induction of maximal respiration by FCCP,
mimicking the state of high ATP demand, TDP1-depleted cells showed
~25% lower spare respiratory capacity (SRC) compared to WT cells
(P < 0.01; Fig. 3H). TOP1mt*-overexpressing cells had less than 25%
SRC compared to control cells (P < 0.01; Fig. 3I). Simultaneous de-
pletion of TDP1 partially rescued this defect to ~50% of the baseline
level. Together, we conclude that TDP1 promotes OXPHOS under
both basal and high energy demands.
Mitochondrial dysfunction is predicted to increase the levels of
cellular free radicals, attacking both nuclear DNA and mtDNA. To ex-
amine the role of TDP1 in the cellular homeostasis of free radicals, we
established vertebrate Tdp1−/− DT40 cells and isogenic lines stably
expressing different levels of hTDP1. TDP1 expression was assessed
by immunoblotting (Fig. 4A) and by a TDP1 enzymatic assay mea-
suring the liberation of tyrosine from 3′-phosphotyrosine oligo-
nucleotide substrates (Fig. 4B) (40). We then used electron spin
resonance (ESR) spectroscopy to directly quantify the levels of carbon-
centered radicals (41, 42). The ESR profile was consistent with that
of nucleic acids, suggesting DNA-derived carbon-centered radicals
(Fig. 4C). Tdp1−/− cells displayed an approximately eightfold increase
in carbon radicals compared to WT DT40 cells. The increase was
TDP1-dependent because expression of hTDP1 in Tdp1−/− cells led
to a significant reduction of carbon adducts (P < 0.05; Fig. 4D). To test
whether this is an epiphenomenon of vertebrate DT40 cells, we
established Tdp1−/−mouse embryonic fibroblasts (MEFs) and an iso-
genic control expressing hTDP1 using retroviral transduction. We first
examined the protective effect of Tdp1 against oxidative free radical
damage induced by H2O2 or ionizing radiation (IR). Consistent with
previous reports using Tdp1−/− mouse astrocytes (43) and chicken
DT40 B-lymphocytes (13), Tdp1−/−MEFs were significantly more sen-
sitive to H2O2 and IR compared to Tdp1
−/−MEFs complemented with
hTDP1 (P < 0.05; Fig. 4, E and F). Our initial experiments revealed a
consistent increase of carbon radicals in Tdp1−/− MEFs compared to
controls. To examine this further, we took advantage of a pathologic
mutant superoxide dismutase 1, SOD1G93A, associated with amyo-
trophic lateral sclerosis. The toxic mutant induces high levels of3 of 15
SC I ENCE ADVANCES | R E S EARCH ART I C L Emitochondrial ROS production throughmultiplemechanisms (44).We
stably overexpressedhumanSOD1or SOD1G93A (hSOD1orhSDO1G93A,
respectively) inTdp1−/−MEFs by retroviral transduction (Fig. 4G) andChiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017then subjected the cell lines toESR analyses.Again, the pattern of carbon-
centered radicals corresponded to that of nucleic acid–derived radicals
(Fig. 4H). Whereas Tdp1−/− cells exhibited an approximately sixfoldA
TOP1mt*-EmGFP
ATP5A (complex V)
UQCRC2 (complex III)
VDAC1/Porin
SDHB (complex II)
CO2 (complex IV)
m
iS
cr
m
iT
DP
1
TO
P1
m
t* 
+ 
m
iS
cr
TO
P1
m
t* 
+ 
m
iT
DP
1
75
(kDa)
50
37
25
20
Complex IIComplex I Complex III
Complex V
B D
E F
m
iS
cr
m
iT
DP
1
TO
Pm
t*
+
m
iS
cr
TO
Pm
t*
+
m
iT
DP
1
0.0
0.5
1.0
1.5
2.0
2.5
R
el
at
iv
e
ex
p
re
ss
io
n
le
ve
l ns
m
iS
cr
m
iT
DP
1
TO
Pm
t*
+
m
iS
cr
TO
Pm
t*
+
m
iT
DP
1
0.0
0.5
1.0
1.5
2.0
2.5
R
el
at
iv
e
ex
p
re
ss
io
n
le
ve
l
m
iS
cr
m
iT
DP
1
TO
Pm
t*
+
m
iS
cr
TO
Pm
t*
+
m
iT
DP
1
0.0
0.5
1.0
1.5
2.0
2.5
R
el
at
iv
e
ex
p
re
ss
io
n
l e
v e
l
**
m
iS
cr
m
iT
DP
1
TO
Pm
t*
+
m
iS
cr
TO
Pm
t*
+
m
iT
DP
1
0.0
0.5
1.0
1.5
2.0
2.5
R
el
at
iv
e
ex
p
re
ss
io
n
le
ve
l
ns
m
iS
cr
m
iT
DP
1
TO
Pm
t*
+
m
iS
cr
TO
Pm
t*
+
m
iT
DP
1
0.0
0.5
1.0
1.5
2.0
2.5
R
el
at
iv
e
ex
p
re
ss
io
n
le
ve
l
ns
Complex IV
ns
(kDa)
50
37
Anti-UQCRC2 (complex III)
Anti-VDAC1
m
iS
cr
m
iT
DP
1
TO
P1
m
t* 
+ 
m
iS
cr
TO
P1
m
t* 
+ 
m
iT
DP
1
C
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Fig. 4. Accumulation of carbon radicals in Tdp1 deficient vertebrate cells. (A) Immunoblotting of cell lysates from Tdp1−/− DT40 cells complemented with hTDP1 or
an empty vector using antibodies against hTDP1. (B) TDP1 enzymatic activity measured on cell lysates from (A) using an in vitro assay with an 18-mer oligonucleotide
substrate containing a 3′-phosphotyrosine residue and a fluorescein isothiocyanate (FITC) molecule conjugated to the 5′-end. Recombinant hTDP1 (rTDP1) was used as
positive control. Fluorescence intensity was measured with a BMG Labtech PHERAstar plate reader and analyzed by the PHERAstar software. (C) ESR spectra obtained
during 30 min of UVA irradiation (approximately 3.1 mW/cm2) of DT40 cells. (D) Bar charts showing the mean integration of all six carbon adducts shown in (C) noted as
a percentage of integrated manganese reference lines. Data are the means of three independent experiments, and error bars represent ±1 SEM. (E and F) MEFs were treated
with the indicated doses of H2O2 for 10 min on ice or exposed to x-ray irradiation at 12 mA/250 kV on ice and then left to recover until macroscopic colonies formed. Surviving
fraction was calculated by dividing the number of colonies on treated plates by the number on untreated plates. Data are the means of three independent experiments, and
error bars represent ±1 SEM. (G) Immunoblotting of Tdp1−/− MEFs complemented with hSOD1 or hSOD1G93A. Expression levels of hSOD1 and hSOD1G93A were quantified by
ImageJ and noted as a fraction relative to endogenous mouse Sod1 (mSod1). (H) ESR spectra obtained during 30 min of UVA irradiation (approximately 5 mW/cm2) of MEFs in
(G). (I) Bar charts showing the mean integration of all six carbon adducts from (G) noted as a percentage of integrated manganese reference lines. SEM was calculated from
three independent experiments. (J and L) Immunoblotting of Tdp1−/− MEF lysates overexpressing hSOD1 or hSOD1G93A. Expression levels of hSOD1 are noted as a fraction
relative to endogenous mouse Sod1 (mSod1). (K and M) Bar charts showing the mean integration of all six carbon adducts noted as a percentage of integrated manganese
reference lines from ESR data obtained from MEFs in (J) and (L), respectively. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.Chiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017 6 of 15
SC I ENCE ADVANCES | R E S EARCH ART I C L Eincrease in carbon adducts compared to controls, overexpression of
hSOD1 led tomarked suppression (P < 0.01; Fig. 4I). In contrast, over-
expression of hSOD1G93A led to an approximately twelvefold increase
incarbonadducts compared tocontrolorTdp1−/−cells (P<0.01;Fig. 4I).To
test whether the increase in carbon adducts was dependent on SOD1G93A
expression levels, we screened and established Tdp1−/− cells expressing
different levels of SOD1G93A (Fig. 4, J and L). Reduction of the ratio of
ectopic hSOD1G93A to endogenous SOD1 expression from 1.1 to 0.8
attenuated the increase in carbon adducts from approximately twelve-
fold to eightfold (Fig. 4K). Furthermore, a further reduction of the ratio
of hSOD1G93A to endogenous Sod1 to 0.37 failed to impact on the level
of carbon adducts compared to levels detected in Tdp1−/− cells (Fig.
4M). Together, we conclude from these experiments that TDP1
controls the level of ROS-induced carbon radicals in vertebrate cells.
To test whether the observed effects on carbon radicals correlate
with nuclear chromosomal breaks, we quantified DNA single-strand
breaks (SSBs) using the alkaline comet assays. For these experiments,
we used a low-doseH2O2 (10 mM) that acts as a substrate for SOD1
G93A,
which converts it to reactive hydroxyl and superoxide radicals through
the Fenton reaction (45–47). After 10 min of H2O2 treatment, Tdp1
−/−
cells displayed approximately twofold more strand breaks than WT
cells, confirming a role for TDP1 in controlling the level of free
radical–induced strand breaks. Overexpression of hSOD1G93A in
Tdp1−/− cells induced approximately threefold more breaks. Converse-
ly, overexpression of hSOD1 in Tdp1−/− cells suppressed the observed
increase in DNA strand breaks to background levels detected in WT
cells (P < 0.001; Fig. 5A). Subsequent incubation in H2O2-free media
led to rapid clearance of SSBs with no detectable difference in repair
kinetics (Fig. 5B). We next examined the effect of modulating endoge-
nous free radicals on cell survival. Consistent with the ESR and comet
assay data, overexpression of SOD1G93A sensitized Tdp1−/− cells to
H2O2, while SOD1 overexpression offered some protection (P < 0.05;
Fig. 5C). In contrast, overexpression of SOD1G93A had no impact on cell
survival of WT cells (Fig. 5D). Having established the protective role of
TDP1 in the multiple cellular systems using a variety of readouts, we
then proceeded to the whole-organism level by crossing Tdp1−/− mice
with hSOD1G93A mice. Our experiments suggested early embryonic le-
thality of the doublemutantmice becausewe only detected three double-
mutant embryos that died in utero (Table 1). However, the rarity of
double mutants in the progeny is due to the proximity of SOD1G93A
and Tdp1 genes, which both lie on distal mouse chromosome 12 (48).
Thus, obtaining double-mutant mice will depend on a rare recombina-
tion event between these two loci to bring the knockoutTdp1portion and
SOD1G93A transgene together on the same chromosome in a SOD1G93A
parent. This is reflected in the number of SOD1G93A; Tdp1+/− offspring,
which was unexpectedly high (96 compared to the expected 54.5).
Finally, the role of TDP1 in protecting from oxidative-induced
nuclear DNA damage could be explained either by its direct role
to process 3′-oxidized DNA breaks or by an indirect role of proces-
sing TOP1-linked DNA breaks induced by H2O2. To ascertain the
relative contribution of these two possibilities, we transiently de-
pleted TDP1 alone or in combination with TOP1 (Fig. 5E). As
expected, depletion of TOP1 reduced the level of CPT-induced
TOP1 cleavage complexes (TOP1-cc), as measured by the modified
alkaline comet assay (Fig. 5F). Subsequent depletion of TOP1
offered a marked protection from H2O2-induced cell kill (P <
0.01; Fig. 5, G and H). Thus, the ability of TDP1 to process nuclear
TOP1-linked breaks induced by oxidative stress plays a major role in
its genome maintenance function.Chiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017DISCUSSION
The proximity of the mtDNA to the ETC complexes increases its vul-
nerability to oxidative damage (49), which can trap TOP1mt and gen-
eratemtPDBs (5). TOP1mt-mediatedmtPDBs can affect transcription in
response to fluctuations in cellular energy demands (24, 50, 51). Although
the repair ofmtPDBs is predicted to play a key role in this response, little
is known about the repair mechanisms. Here, we describe a novel
mtDNA repair pathway driven by TDP1 and report its importance
in maintaining mitochondrial gene transcription and bioenergetics.
Mitochondrial genetic information is tightly packed inmtDNA, and
both strands are actively transcribed with one noncoding regulatory
region containing the promoters for mtDNA transcription. Because
mtDNA is circular, bidirectional transcription results in rapid accumu-
lation of negative supercoils behind the RNA polymerases, which re-
quire removal by TOP1mt activity akin to the reported roles of
nuclear TOP1 during transcription (52, 53). Although Top1mt−/−
MEFs accumulate more negative supercoils in mtDNA, the consequences
of accumulation of TOP1mt-linked DNA breaks on mitochondrial gene
transcriptionhavenotbeenexamined.Themeasurementof transcript abun-
dance by qRT-PCRgenerally reflects transcript turnover, which is a product
ofboth transcription rate and transcript stability. In thecontextofmitochon-
drial genes,whichare translated inorganello, defectivemRNAtransport that
can lead to transcript accumulation is ruled out. Top1mt−/−MEFs did not
accumulate aberrant length mitochondrial transcripts (21), arguing against
an essential role ofTOP1mt in transcription elongation. Furthermore, the
peak of TOP1mt binding in the noncoding regulatory region containing
the two promoters strongly suggests its involvement in transcription
initiation (54), which is the rate-limiting factor in determining tran-
script abundance. Thus, transcript abundance measured by qRT-PCR
in our system predominantly reflects the transcription rate.
TOP1mt-cc fractionation data suggest that transient (up to 48 hours)
overexpression of TOP1mt in TDP1-proficient cells in the absence of
topoisomerase poisons leads to mild accumulation of mtPDBs, whereas
overexpression of TOP1mt* led to a more robust increase. TOP1mt
overexpression in TDP1-proficient cells led to a marked reduction of
mitochondrial mRNA transcripts, which is consistent with previous re-
ports (21, 55). In contrast, overexpressionof TOP1mt* resulted in higher
transcript levels. Therefore, the steady-state level of TOP1mt-cc seems to
positively correlate with mitochondrial transcription level. One possible
explanation is through DNA damage–mediated retrograde signaling,
which can up-regulate mitochondrial transcription and biogenesis
(24, 56–60). TDP1 activity is also moderately up-regulated in our
cellular model, tentatively suggesting its involvement in the retrograde
signaling response. It may also suggest a nuclear-mitochondrial trans-
location in response to mitochondrial stress, which is consistent with a
previous report (19). These data also provide an explanation for the lack
of change inmitochondrialmass followingTOP1mt* expression inmu-
rine cells despite rapid mtDNA depletion (33), further confirming the
importance of the mitochondrial TDP1 pathway to remove mtPDBs
and maintain overall mitochondrial integrity.
Although translationofmitochondrial-encodedgenesoccurs inorganel-
lo, assembly of the ETC requires importation of nuclear-encoded subunits.
Given that nuclear transcription of ETC subunits is unaffected, changes in
levels of the mitochondrial subunits can potentially disrupt the nuclear/
mitochondrial stoichiometry, resulting in dysfunctional ETC. Intriguingly,
although the levels of multiple mitochondrial transcripts are affected by the
TOP1mt/TDP1 pathway, only complex III showed particular sensitivity to
structural disruption. Complex III, also known as cytochrome bc1 complex,
is encodedbyCYTB in themitochondria, and the remaining10 subunits are7 of 15
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Fig. 5. TDP1 protects mammalian cells from ROS-induced chromosomal breaks. (A) The indicated MEF cell lines were incubated with 10 mM H2O2 for 10 min and
then left to repair in drug-free medium at 37°C for the indicated time periods. DNA SSBs were measured using the alkaline comet assay. Average tail moments from 50 cells
were quantified using the Comet Assay IV software. Data are the means of three independent experiments, and error bars represent ±1 SEM. (B) Repair kinetics of cells
from (A) expressed as a percentage of remaining breaks over time. (C) Cells from (A) were treated with the indicated concentrations of H2O2 for 10 min on ice and then
left to recover until macroscopic colonies formed. Surviving fraction was calculated by dividing the number of colonies on treated plates by the number on untreated
plates. Data are the means of three independent experiments, and error bars represent ±1 SEM. (D) MEFs were treated with the indicated concentrations of H2O2 and
processed as described in (C). Data are the means of three independent experiments, and error bars represent ±1 SEM. (E) Immunoblotting of fractionated MRC5 cell
lysates from cells containing control short hairpin RNA (Ctrl shRNA) and shRNA against TOP1 (shTOP1), TDP1 (shTDP1), or both. (F and G) MRC5 cells from (E) were
treated with 50 mM CPT for 1 hour (F) or 45 mM H2O2 for 10 min (G) and immediately lysed in buffer containing proteinase K, and TOP1-cc was quantified by the
modified alkaline comet assay. Data are the means of three independent experiments, and error bars represent ±1 SEM. (H) MRC5 cells from (E) were treated with 10 mM
H2O2 for 10 min on ice and then left to recover until macroscopic colonies formed. Surviving fraction was calculated by dividing the number of colonies on treated
plates by the number on untreated plates. Data are the means of three independent experiments, and error bars represent ±1 SEM.Chiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017 8 of 15
SC I ENCE ADVANCES | R E S EARCH ART I C L Eall encoded in the nuclear genome. The cytochrome b subunit is the main
transmembrane subunit that anchors the complex, which could explain the
loss of complex III subunits in TDP1-depleted cells with or without
TOP1mt* overexpression.
Because complex III plays a crucial role in handling electron
transfer, dysfunction of complex III is expected to impair OXPHOS
and increase ROS production. TDP1 depletion or TOP1mt* over-
expression led to a reduction in OXPHOS-specific oxygen consumption,
as measured by the Seahorse bioenergetics assays. Overexpression of
TOP1mt* in TDP1-proficient cells resulted in severe reduction in spare
respiratory capacity, indicating that the ETC function is likely to de-
compensate under conditions of high ATP demand. Furthermore, deple-
tion of TDP1 in these cells partially rescued the spare respiratory capacity,
suggesting that up-regulation of mitochondrial transcription has an added
detrimental effect on mitochondrial bioenergetics compared to suppres-
sion of transcription, possibly through excessive consumption of ATP.
To assess the levels of ROS associated with OXPHOS dysfunction
in the absence of TDP1, we used ESR spectroscopy for the first time to
directly measure the level of intracellular free radicals in vertebrate
cells. We used DT40 cells for these experiments because it was not
possible to titrate the level of TDP1 using the inducible human system.
Ultraviolet A (UVA) irradiation of DT40 andMEFs produced an ESR
detectable carbon-centered adduct as the predominant radical adduct
trapped by 5,5-dimethyl-1-pyrroline N-oxide (DMPO) (61). The ad-Chiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017ducts are formed intracellularly because they were detected after re-
moval of extracellular DMPO by washing with phosphate-buffered
saline (PBS), and their profile is comparable to the carbon adduct de-
tected in UVA-irradiated isolated cell nuclei. These data are also
consistent with reports showing the formation of singlet oxygen upon
UVA irradiation and the photoproduction of hydrogen peroxide and
superoxide anion radical (O2
−) (62, 63). We consistently detected
higher levels of carbon adducts in TDP1-deficient compared to
TDP1-proficient cells. The level of carbon adducts was consequently
suppressed by the overexpression of SOD1, in line with previous re-
ports (41). In contrast, overexpression of a toxic mutant of SOD1
(SOD1G93A) led to a marked increase in carbon-centered adducts.
The impact of SOD1 and SOD1G93A on carbon adducts was dependent
on the extent of their respective expression levels. The carbon radical
adducts detected here are mobile and most likely located on exposed
DNA structures such as those produced from nucleic acid fragments
formed after DNA strand breaks and for which TDP1 is required for
processing (41, 42). Consistent with the role of TDP1 as protection
against oxidative DNA damage, Tdp1−/− cells accumulated more
DNA strand breaks and displayed hypersensitivity to H2O2. Overex-
pression of SOD1G93A led to a further increase in strand breaks and sen-
sitization, whereas overexpression of SOD1 offered some protection.
The cellular ESRdata reported here and elegant cell-free biochemical
experiments reported by the Povirk and Interthal groups demonstrate aTable 1. Genotypes of live offspring of crossing hSOD1G93A with different Tdp1 backgrounds. Male mice overexpressing hSOD1G93A were bred with
female WT mice, heterozygous for Tdp1 or homozygous for Tdp1 knockout. The live births were genotyped at 1 month postnatum.Male parent Parent hSOD1G93A Tdp1+/−Female parent Sod1+/+ Tdp1−/− Sod1+/+ Tdp1+/− Sod1+/+ Tdp1+/+Offspring (no. of live births) Expected Obtained Expected Obtained Expected ObtainedSod1+/+ Tdp1+/+ 6.25 3 2.25 0Sod1+/+ Tdp1+/− 54.5 6 12.5 5 2.25 4Sod1+/+ Tdp1−/− 54.5 115 6.25 14hSOD1G93A Tdp1+/+ 6.25 14 2.25 5hSOD1G93A Tdp1+/− 54.5 96 12.5 12 2.25 0hSOD1G93A Tdp1−/− 54.5 1* 6.25 2Total 218 218 50 50 9 9Male parent hSOD1G93A; Tdp1+/+Female parent Sod1+/+; Tdp1−/− Sod1+/+; Tdp1+/− Sod1+/+; Tdp1+/+Offspring (no. of live births) Expected Obtained Expected Obtained Expected ObtainedSod1+/+; Tdp1+/+ 15.25 9 7 6Sod1+/+; Tdp1+/− 24.5 21 15.25 15Sod1+/+; Tdp1−/−hSOD1G93A; Tdp1+/+ 15.25 23 7 8hSOD1G93A; Tdp1+/− 24.5 28 15.25 14hSOD1G93A; Tdp1−/−*Total 49 49 61 61 14 14*One fetus demised in utero.9 of 15
SC I ENCE ADVANCES | R E S EARCH ART I C L Edirect role for TDP1 in processing a wide variety of oxidized DNA frag-
ments (2–4, 64). However, oxidative DNAdamage has also been shown
to trap TOP1 onDNA (28, 65, 66), which requires TDP1 for repair (67).
To ascertain the relative contribution of TDP1 in processing oxidative
DNA breaks per se and TOP1-mediated PDBs triggered by oxidative
damage, we transiently depleted TOP1 and monitored PDBs using a
modification of the alkaline comet assay (16, 68). TOP1 depletion sup-
pressed CPT-induced PDBs and led to a marked protection from cell
death induced by oxidative stress, suggesting that TOP1-mediated
PDBs are major contributors to cell death induced by oxidative DNA
breakage in situations where TDP1 is limiting.
The data reported here demonstrate a role for TDP1 in maintaining
mtDNA transcription and bioenergetics, thereby controlling the level of
free radical–inducedDNAdamage. This role is fulfilled through a func-
tional interaction between TDP1 and both nuclear and mitochondrial
TOP1. We propose that, in the mitochondria, the catalytic cycle of
TOP1mt is facilitated by the removal of TOP1mt-cc by TDP1. Tran-
scription of the mitochondrial subunits of the ETC complexes is
balanced with transcription of the nuclear subunits, ensuring proper
assembly of the ETC complexes. Efficient functioning of ETC
complexes promotes ATP production by OXPHOS, generating a
membrane potential that prevents formation of ROS (Fig. 6A). In
the absence of TDP1, unrepaired TOP1mt-cc inhibits mitochondrial
transcription, thereby disrupting the stoichiometry of the ETC sub-
units. OXPHOS efficiency is reduced, negatively affecting ATP pro-
duction and increasing the formation of ROS (Fig. 6B).When excessive
TOP1mt-cc is formed, for example, due to trapping by oxidized DNA
lesions or TOP1mt poisons, compensatory up-regulation of TDP1
activity accelerates TOP1mt catalytic cycle and promotes mitochon-
drial transcription. However, without a proportional increase in nu-
clear transcription, misassembly of the ETC complexes takes place,
which cannot be compensated for by TDP1, and thus leads to a reduc-
tion in OXPHOS and an elevation in ROS production (Fig. 6C).
The role of nuclear-encoded TDP1 to maintain mitochondrial ge-
nome stability highlights the importance of nuclear-mitochondrial in-
teractions, which should be considered during mitochondrial donation
procedures or otherwise known as three parent babies recently licensed
in the UK. Notably, accumulation of nuclear PDBs is pathogenic in a
number of neurological disorders such as spinocerebellar ataxia with
axonal neuropathy (SCAN1) and ataxia telangiectasia (14). Given the
high metabolic activity and energy demand of cells in the nervous sys-
tem, the data reported here suggest that accumulation of mitochondrial
PDBs may also be pathogenic, disrupting mitochondrial gene
transcription and bioenergetics, thereby causing progressive neuronal
demise. Moreover, the functional interaction between TDP1 and
TOP1mt may play an important role in other clinical settings. For ex-
ample, TOP1mt has been recently shown to promote liver regeneration
(23). Pathological and drug-induced liver injuries often require partial
liver transplantation, the success of which differs across individuals.
This study suggests the importance of assessing TDP1 and TOP1mt
genetic variants and function to improve the success of tissue regenera-
tion. Furthermore, several cancer cell types show increased mitochon-
drial genomic mutations and up-regulation of nuclear-encoded
enzymes that maintain mitochondrial genome stability (69). For exam-
ple, TOP1mt transcription is up-regulated by the proto-oncogeneMyc
(70), offering a clinical settingwhereTDP1 inhibitorsmay be synergistic
with TOP1mt poisons such as lamellarin D (51). On the other hand,
TDP1 inhibitors should be avoided in combination with doxorubicin,
which is a TOP2 poison with cardiotoxic side effects shown to be exa-Chiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017cerbated by TOP1mt deletion (22, 71). It would also be interesting to
examine whether the TOP1mtT554A/N558H mutation is common in
cancer patients because our data suggest that this mutation drives an
increase in mtDNA gene transcription, which is fully dependent on
TDP1. Thus, TDP1 inhibitors may offer a selective advantage in this
cohort of tumors. What drives an adaptive advantage for cancer
(whether it is the up-regulation or down-regulation of mtDNA
transcription) remains to be clarified. Nevertheless, targeting the adapt-
ive mechanism in cancer offers a worthy therapeutic opportunity.MATERIALS AND METHODS
Cell lines and plasmids
Tdp1−/−MEFswere generated and genotyped as previously described (43).
Immortalization of Tdp1−/− MEFs was achieved by continuous passageMito. transcription Mito. transcription 
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Fig. 6. Model depicting the importance of the TDP1/TOPmt repair pathway.
(A) Under basal condition, the catalytic cycle of TOP1mt is facilitated by the removal
of TOP1mt-cc by TDP1. Transcription of the mitochondrial subunits of the ETC
complexes is balanced with transcription of the nuclear subunits, resulting in the
proper assembly of the ETC complexes. Efficient functioning of ETC complexes pro-
motes ATP production by OXPHOS, generating membrane potential that prevents
formation of ROS. (B) In the absence of TDP1, TOP1mt-cc accumulate, which inhibit
mitochondrial transcription without affecting transcription of the nuclear subunits,
leading to misassembly of complex III. OXPHOS efficiency is reduced and ROS
production is increased. (C) When excessive TOP1mt-cc are formed (for example,
because of trapping by oxidized DNA lesions or TOP1mt poison), compensatory
up-regulation of TDP1 activity accelerates TOP1mt catalytic cycle andpromotesmito-
chondrial transcription. However, without proportional increase in nuclear
transcription, misassembly of ETC complexes leads to a reduction in OXPHOS and
an elevation of ROS production. Mito., mitochondrial; Nucl., nuclear.10 of 15
SC I ENCE ADVANCES | R E S EARCH ART I C L Eover at least 3months. ImmortalizedMEFsweremaintained inDulbecco’s
modified Eagle’s medium (DMEM) supplemented with 15% fetal calf se-
rum(FCS), 1×nonessential aminoacids, 2mML-glutamine, andpenicillin-
streptomycin (100 U/ml). Immortalized Tdp1−/− MEFs were stably
transduced with retroviral particles containing hTDP1 complementary
DNA (cDNA) (NM_018319) or humanWT SOD1 or SOD1G93A cDNA
(NM_000454) using the packaging cell line Phoenix (gift from C. Vens)
transiently transfected with the plasmid pMX-PIE containing cDNAs of
the relevant genes. Transduced clones were pooled and maintained in
growth medium containing puromycin (1 mg/ml). TDP1−/− DT40 lym-
phocytes (15) were maintained in RPMI 1640 supplemented with 10%
FCS, 1% chicken serum, 2 mM L-glutamine, 1 mM b-mercaptoethanol,
and penicillin-streptomycin (100 U/ml) and grown at 39°C. MRC5 cells
stably transduced with shTOP1-containing lentiviral particles, as previ-
ously described (11), were grown in MEM containing 10% FCS, 2 mM
L-glutamine, penicillin-streptomycin (100U/ml), andpuromycin (1mg/ml).
Flp-In T-Rex 293 cells were maintained in DMEM supplemented with
15% tetracycline-free FCS, 2 mM L-glutamine, penicillin-streptomycin
(100 U/ml), zeocin (100 mg/ml), and blasticidin (10 mg/ml). The two
miRNA targeting regions of the TDP1 open reading frame (ORF)
(5′-TGGACCATCTAGTAGTGAT-3′ and 5′-TGGTGTCTCCAG-
CAGTGAT-3′) were inserted into the plasmid pcDNA6.2-G.W.-
EmGFP (Life Technologies) following the manufacturer’s instructions.
To subclone the miRNA and the EmGFP sequences into pcDNA5-
FRT/TO/His (Life Technologies), restriction sites Hind III and Not I
were introduced using divergent PCR with the following primers: 5′-
GGCGGCAAGCTTACAAGTTTGTACAAAAAAGCAG-3′ and 5′-
GGCGGCGCGGCCGCACCACTTTGTACAAGAAAGCTG-3′. To
generate RNAi-resistant TDP1, silent mutations were introduced in
the TDP1 ORF using the following PCR primers: 5′-GAGGTTCAC-
GATATCAAGCAGCGACGAAAGTGAGGAAGAAAAG-3′ and 5′-
CTTTCGTCGCTGCTTGATATCGTGAACCTCCCATAATCGC-3′.
The TDP1 fragment was PCR-amplified using the following primers:
5′-aagcaggctttaaaaccATGGAACAAAAACTTATTTCTGAAGAA-
GATC-3′ and 5′-gcccttgctcaccatGGAGGGCACCCACATGTT-3′. In
parallel, the backbone vector pcDNA5-FRT-EmGFP-pre-miRNA was
amplified using the following primers: 5′-ATGGTGAGCAAGGGC-
GAG-3′ and 5′-GGTTTTAAAGCCTGCTTTTTTGTAC-3′. Both am-
plicons were gel-purified and ligated at a backbone-to-insert ratio of 1:3
using the Gibson Assembly Master Mix (New England Biolabs)
according to the manufacturer’s instructions. The resulting pcDNA5-
FRT construct was used together with the Flp recombinase–expressing
plasmid pPGKFLP to cotransfect the Flp-In T-Rex 293 cells. Single
clones that have stably integrated the construct were selected with
hygromycin B (100 mg/ml) for 3 weeks and maintained in media
containing hygromycin B (100 mg/ml) and blasticidin (10 mg/ml).
Transcription of miRNA or cDNA was induced by incubation in dox-
ycycline (1 mg/ml) for 24 to 48 hours.
Immunoblotting
Cells were lysed in 50 mM tris, 40 mM NaCl, 2 mM MgCl2, 0.5%
Triton X-100, 1× protease inhibitors cocktail, and benzonase nuclease
(25 U/ml) for 1 hour at 4°C. Cell lysate was cleared by centrifugation
for 10 min at 4°C. Total protein concentration was determined using
Bradford assay and fractionated by SDS–polyacrylamide gel electro-
phoresis. The following primary antibodies were used: 53BP1 (A300-
273A, Bethyl Laboratories), b actin (AC-40, Sigma-Aldrich), b tubulin
(ab7792, Abcam), GFP (ab290, Abcam), OXPHOS antibody cocktail
(ab110411, Abcam), SOD1 (FL-154, Santa Cruz Biotechnology), TDP1Chiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017(ab4166, Abcam), TOP1 (C-21, Santa Cruz Biotechnology), VDAC1/
Porin (ab15895, Abcam), and UQRC2 (ab14745, Abcam).
Detection of TOP1mt-cc by cesium chloride fractionation
Flp-In cells (2 × 107) were induced with doxycycline (1 mg/ml) for
48 hours and harvested. Mitochondria were isolated using the mito-
chondria isolation kit for cultured cells (89874, ThermoFisher Scientific)
following the manufacturer’s instructions. Lysis of mitochondria and
CsCl fractionation of TOP1mt*-cc were carried out as previously de-
scribed (72). TOP1mt*-cc were detected using antibodies against
TOP1-DNA covalent complexes (MABE1084, Millipore) or GFP (ab290,
Abcam) and visualized by chemiluminescence.
Chromatin immunoprecipitation–PCR
Flp-In T-Rex 293 cells (1.5 × 107) were induced by doxycycline (1 mg/ml)
for 48 hours, scraped, and then lysed in 0.5 ml of chromatin immu-
noprecipitation (ChIP) lysis buffer [50 mM Hepes-KOH (pH 7.5),
140 mMNaCl, 1 mM EDTA (pH 8), 1% Triton X-100, 0.1% sodium
deoxycholate, 0.1% SDS, and 1× protease inhibitor] on ice for 30 min.
Chromatin was sonicated to yield fragments of 200 to 300 base pairs.
Ten percent of the volume of the supernatant was taken as input and
snap-frozen. The remainder was diluted fourfold in radioimmunopre-
cipitation assay buffer [50 mM tris-HCl (pH 8), 150 mM NaCl, 2 mM
EDTA(pH8), 1%NP-40, 0.5% sodiumdeoxycholate, 0.1%SDS, and 1×
protease inhibitors] and added to 20 ml of GFP-Trap magnetic agarose
beads (ChromoTek) on a rotating carousel overnight at 4°C. The beads
were thenwashed twice with low-salt wash buffer [0.1% SDS, 1%Triton
X-100, 2mMEDTA, 20mMtris-HCl (pH8), and 150mMNaCl], twice
with high-salt wash buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20mMtris-HCl (pH 8), and 500mMNaCl], followed by onewashwith
lithium chloride buffer [0.25 M LiCl, 1% NP-40, 1% sodium deoxy-
cholate, 1 mM EDTA, and 10 mM tris-HCl (pH 8)], and twice with
TE buffer. The immunoprecipitated complex was then eluted from
the beads in 150 ml of elution buffer (1% SDS and 100mMNaHCO3).
The eluent and the input samples were then treated with RNase A
and proteinase K. The DNA was purified using phenol chloroform
extraction and ethanol precipitation. The pellet was resuspended in
30 ml of distilled water.
For qPCR, the input and ChIP samples were diluted 1:10, and
then, 5 ml was mixed with 2.8 ml of 5 mM forward and reverse primers
(5′-TACTCAAATGGGCCTGTCCT-3′ and 5′-TGGTACCCAA-
ATCTGCTTCC-3′, respectively) and 10 ml of 2× SensiMIX SYBR
Hi-ROX mastermix (QT605-05, Bioline). The mastermix was ali-
quoted into reaction volumes (20 ml) in duplicates using automated
PCR setup workstation (CAS-1200, Corbett Robotics). The PCR re-
actions were carried out with thermocycling conditions of 95°C for
10min and then 40 cycles at 90°C for 15 s, 50°C for 15 s, and 72°C for
30 s, with signal acquisition at the end of each cycle. Quantification
of chromatin enrichment was calculated by percent input normal-
ized to the mtDNA copy number in the input samples.
Mitochondrial gene transcription
Total RNA from 5 × 106 cells was extracted using Qiagen RNeasy Plus
kit as per the manufacturer’s instructions, which included DNase
treatment of the samples, followed by reverse transcription of 5 mg
of total RNA using the Tetro cDNA Synthesis Kit (Bioline). PCR prim-
ers used were as follows: GGAGCAGGAACAGGTTGAACAG
(CO1 forward) and GTTGTGATGAAATTGATGGC (CO1 reverse);
CCCTTACCATCAAATCAATTGGCC (CO2 forward) and11 of 15
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CCCTTCGCTGAC (ND1 forward) and GGATTGAGTAAACG-
GCTAGGC (ND1 reverse); CTGATCCTCCAAATCACCACAG
(CYT-B forward) and GCGCCATTGGCGTGAAGGTA (CYT-B re-
verse); TAGAGGAGCCTGTTCTGTAATCGAT (RNR1 forward) and
CGACCCTTAAGTTTCATAAGGGCTA (RNR1 reverse); ACAT-
CGCTCAGACACCATG (GAPDH forward) and TGTAGTTGAGGT-
CAATGAAGGG (GAPDH reverse). qPCR was set up in a 20-ml
reactionusing 5ml of 1:10 dilutionof cDNAsamples and 0.7mMprimers
in 1× SensiMIX SYBR Hi-ROX mastermix (Bioline) in a Rotor-Gene
6000 qPCRmachine (Corbett Research). The thermocycling conditions
were 95°C for 10 min, followed by 40 cycles at 95°C for 15 s, 50°C for
15 s, and 72°C for 30 s.
Gel-shift TDP1 activity assay
Reactions were performed in reaction volumes (10 ml) containing assay
buffer [25 mMHepes (pH 8.0), 130 mMKCl, and 1 mM dithiothreitol
(DTT)], 100 ng of mitochondrial lysate, and 75 nM Cy5.5-labeled sub-
strate oligomer containing a 3′-phosphotyrosyl group, 5′-(Cy5.5)
GATCTAAAAGACT(pY)-3′ (Midland Certified Reagent Company).
Reactions were carried out at 37°C for 1 hour and stopped by the addi-
tion of 10 ml of loading buffer (44%deionized formamide, 2.25mM tris-
borate, 0.05 mM EDTA, 0.01% xylene cyanol, and 1% bromophenol
blue). Samples were then heated at 90°C for 10 min before separation
on a 20% urea SequaGel (Thermo Fisher Scientific) by gel electropho-
resis at 150 V for 1 hour. Reaction products were visualized by Bio-Rad
ChemiDocMP image docking system at 635 nm, and bandswere quan-
tified using LI-COR Image Studio Lite version 5.2.
TDP1 activity assay: Fluorescence assay
In vitro 3′-tyrosyl-DNA phosphodiesterase activity of whole-cell
extracts (WCE) was determined as previously described (40). Briefly,
assays were performed in a 15-ml reaction volume containing assay
buffer [50 mM tris (pH 8.0), 5 mMMgCl2, 80 mM KCl, 0.05% Tween
20, and 1mMDTT], 10 nM 13-mer substrate with a 3′-phosphotyrosyl
oligonucleotide conjugated to an FITCmolecule (MidlandCertified Re-
agent Company), and 2 ml (~2 mg) of the indicated amounts of WCE.
Reactions were carried out at room temperature for 10 min before
quenching with a mix of 30 ml of enhancer and 2 ml of sensor (Gyrasol
Technologies). Fluorescence intensity was measured using a BMG Lab-
tech PHERAstar plate reader at an excitation wavelength (lex) of 490 nm
and an emission wavelength (lem) of 520 nm. Recombinant hTDP1
(6.5 pM) diluted in assay buffer was used as a 3′-tyrosyl-DNA phos-
phodiesterase activity control.
Mitochondrial bioenergetic profiling by
Seahorse Bioanalyzer
Flp-In T-Rex 293 cells were induced in doxycycline (1 mg/ml) for
24 hours and then seeded (6 × 104 cells per well) in a 24-well Seahorse
cell culture plate (100777-004, SeahorseBioscience) precoatedwithCell-
Tak cell adhesive in 575 ml of XF assay media (101022-100, Seahorse
Bioscience) supplementedwith glucose (4.5mg/ml), 2mML-glutamine,
and 1× sodiumpyruvate. Cells were incubated at 37°Cwith atmospheric
CO2 for 1 hour. A XF24 flux plate prehydrated in calibrant buffer was
loaded with 10 mM oligomycin, FCCP, and rotenone (final concentra-
tion, 1 mM) diluted in the supplemented XF assay medium. Three basal
readings were taken (3 min each), followed by addition of oligomycin,
FCCP, and rotenone, with three readings taken after the addition of
each drug. Cells were washed with PBS once and then incubated inChiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017DMEM containing Hoechst 33342 (25 mg/ml) at 37°C for 30 min.
The images were captured with an IN Cell Analyzer 6000 cell imaging
system (GEHealthcare), and the nuclei number in each well was quan-
tified using the IN Cell Developer software (GE Healthcare).
ESR spectroscopy
ESR experiments were undertaken using a JEOL FA100 Spectrometer
with the following typical settings: microwave power, 20 mW; modula-
tion, 0.2 mT; signal amplitude, 2 × 103; sweep time, 5 s with repeated
scanning (25 scans). For irradiations, a 300-W Oriel Xenon lamp
(ozone-free) was used, and radiation >260 nm passed through a water
filter to remove infrared radiation and then two optical glass filters (4- to
5-mm-thick WG320 Schott filter, UQG Optics Ltd.) to filter UVB/
UVC. In studies involving MEFs, an irradiance of 40 mW/cm2
(UVA-visible light) was measured at the distance of the sample from
the fiber-optic probe using an ILT1400-A Radiometer photometer
equipped with a thermopile detector measuring radiation over the full
spectral range. In studies of DT40 cells, a UVA-visible irradiance of
25 mW/cm2 was measured at the position of the sample. Using a 1:7
ratio of UVA to visible light from solar simulator spectral irradiance
data (Oriel Instruments Light Sources Catalog), it was estimated that
the UVA irradiance at the position of the cells in the spectrometer
was approximately 3.1 to 5 mW/cm2 of UVA and comparable to sun-
shine in southern latitudes. ForDT40 cells, 60 × 106 cells were harvested
and then incubatedwith the spin-trapping agent DMPO (0.9M in PBS)
for 60 min at room temperature. Cells were then washed with 10 ml of
PBS, centrifuged, resuspended in 187 ml of PBS (320,000 cells/ml), and
loaded in the ESR quartz cell. For MEFs, 107 cells were harvested, and
DMPO-treated cells were resuspended in 125 ml of PBS (80,000 cells/ml).
All cells were then exposed to UVA-visible light irradiation for 30 min
in situ and free radical adducts were measured in real time. The ESR
profile consisted of nucleic acid–derived radicals (R.H., in preparation),
and quantification of the UVA-induced carbon radical was conducted
by integration of the low-field signal of the carbon adduct relative to the
Mn line (of the internal manganese reference sample in the spectrom-
eter) in line with previous ESR quantifications (73).
Alkaline comet assays and the modified alkaline
comet assays
Immortalized MEFs or Flp-In T-Rex 293 cells (~3 × 105 cells per sam-
ple) were suspended in normal growth media (for IR and CPT treat-
ments) or cold PBS (for H2O2 treatment) and subjected to 20-gray
gamma ray, 14 mM CPT for 1 hour at 37°C, or 10 mMH2O2 for 10 min
on ice, and then incubated in normal growth media at 37°C for the in-
dicated repair time. Repair was stopped by placing cells on ice and re-
placing media with cold PBS. Approximately 5000 cells were mixed
with equal volumes of PBS and 1.2% type VII agarose at 42°C, plated
on frosted microscope slides precoated with 0.6% agarose, and chilled
until set. Cells were then lysed in 2.5MNaCl, 10mM tris-HCl, 100mM
EDTA (pH 8), 1% Triton X-100, and 1% dimethyl sulfoxide (DMSO)
(pH 10) at 4°C for 1 hour and washed twice with cold distilled water.
Slides were equilibrated in alkaline electrophoresis buffer (50 mM
NaOH, 1 mM EDTA, and 1% DMSO) for 45 min and then subjected
to electrophoresis at 12 V (100mA) for 25min. Quantification of DNA
breaks was performed usingCometAssay IV software, counting 50 cells
per sample. The modified alkaline comet assay detects PDBs and was
conducted as previously described (16). Briefly, proteinase K (0.8 mg/ml)
was added to the cells immediately after CPT or H2O2 treatment. Cells
were then mixed with equal volumes of PBS and 1.2% type VII agarose12 of 15
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Lysis was performed in the presence of proteinase K (0.4 mg/ml) at
37°C for 3 hours. Slides were then processed as described above.
Clonogenic survival assay
MEFs were seeded at 2000 to 10,000 cells in 10-cm petri dish and in-
cubated overnight in normal growth media. Cells were incubated with
CPT for 1 hour at 37°C and exposed to x-ray (250 kV at 12 mA) or
H2O2 (10 min on ice) at the indicated doses. Cells treated with CPT
or H2O2 were washed twice with PBS and grown in drug-free media
for 7 days. Cells were then fixed with 80% ethanol for 15 min and
stained with 1% methylene blue. Surviving fraction was calculated by
dividing the number of colonies normalized to cell numbers on treated
plates by the number of colonies normalized to cell numbers on un-
treated plates. The average ±1 SEM was calculated from three in-
dependent biological repeats. MRC5 cells with TOP1 or TDP1
shRNA knockdown were seeded at 500 to 2000 cells in 10-cm dishes
and incubated at 37°C for 5 hours or until they became adherent. Cells
were then treated with H2O2 for 10 min on ice at the indicated doses.
Cells were washed twice with PBS and grown in drug-free media for
7 days. Cells were then fixed with 80% ethanol for 15 min and stained
with 1%methylene blue. Percentage of colony survival was normalized
to mock-treated sample.
Cell viability assay
Flp-In T-Rex 293 cells were induced with doxycycline (1 mg/ml) for
24 hours, seeded at densities of 2000 to 20,000 cells per 100 ml, and
treated with the indicated concentrations of CPT in the absence of
doxycycline for 72 hours. Cell viability was measured using the CellTiter-
Blue kit (Promega). The CellTiter-Blue reagent (20 ml) was mixed with
the cells and incubated at 37°C for 1 hour. Fluorescence intensity was
measured at an excitation/emission wavelength of 544/590 ± 10 nm
using a FLUOstar Omega plate reader (BMG Labtech). Viability of un-
treated cells was set to 1, and error bars represent SE from three in-
dependent biological repeats.
Genotyping
Tdp1−/−micewere generated as previously described (43).Tdp1+/−mice
were mated with SOD1G93A mice (74) to generate Tdp1+/− SOD1G93A
males, which were backcrossed with Tdp1+/+, Tdp1+/−, or Tdp1−/−
females. Genotyping of adult mice was conducted using tail biopsies,
which were digested in 100 ml of 25 mM NaOH at 95°C for 2 hours
and diluted with 400 ml of 10 mM tris-HCl (pH 8). Lysate (5 ml) was
used as template in PCR reactions, as previously described (74). Geno-
typing for SOD1G93A was performed using primers 5′-CATCAGCCC-
TAATCCATCTGA-3′ and 5′-CGCGACTAACAATCAAAGTGA-3′.
All animals were housed and maintained in accordance with the insti-
tutional animal care and ethical committee at the University of Sussex.
Statistical analyses
For the survival assays, the mean and SEs were calculated from at least
three biological repeat experiments consisting of three technical repli-
cates at each treatment condition. The P values of samples from each
time point or concentration were analyzed by two-tailed paired Stu-
dent’s t test. For the alkaline comet assays, the mean and SEs were
calculated from at least three biological repeat experiments consisting
of tail moment scores from 50 cells. For the H2O2 comet assay, the
mean comet tail moments of all samples were normalized to the
mock-treated WT sample. The P values of samples from each timeChiang et al., Sci. Adv. 2017;3 : e1602506 28 April 2017point or concentration were analyzed by two-tailed paired Student’s
t test. For qRT-PCR experiments, a standard curve was generated
from pooled cDNAs from all cell lines serially diluted over 10-,
100-, and 1000-fold. Relative quantification of the Ct (threshold cycle)
values of all samples was extrapolated from the standard curve and
normalized against GAPDH values. The normalized values were then
expressed as fold change relative to the miScr cell line. The mean
values and SEs were calculated from three biological repeat exper-
iments. The P values were calculated using two-way analysis of vari-
ance (ANOVA) with Bonferroni post hoc test using GraphPad Prism
version 6 (GraphPad Software).SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/4/e1602506/DC1
fig. S1. The generation of an inducible TDP1 knockdown system in Flp-In T-Rex 293 cells.
fig. S2. Quantification of TOP1mt-cc in TOP1mt-overexpressing cells.
fig. S3. TDP1 depletion had no impact on the expression of the nuclear-encoded complex II
subunit.
fig. S4. TDP1 depletion or TOP1mt* expression does not affect uncoupled respiration
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